Olaratumab | m-entrepreneurship.com

Product Name :
Olaratumab

Search keywords :
Olaratumab

drugId :
null

Target Vo:
Platelet-derived growth factor receptor alpha

Target Vo Short Name :
PDGFR-α

Moa_Name:
Platelet-derived growth factor receptor alpha inhibitors

First Approval Country :
United States

First Approval Date Filter:
2016

Origin Company_Name :
Eli Lilly And Company

Active Company_Name :
Eli Lilly And Company

Active Indication_Name:
Sarcoma

In Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
LAMP1 Antibody
p21 Antibody (YA254)
Glutathione Synthetase Antibody: Glutathione Synthetase Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to Glutathione Synthetase. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts